Prior art

The patent US12138052B1, titled "Blood sample optimization device," was granted on November 12, 2024, from an application filed on July 24, 2024. The earliest priority date for this patent is July 24, 2015.

The authoritative patent text provided does not include the claims section of US12138052B1. Without the claims, a direct analysis of which specific claims are potentially anticipated under 35 U.S.C. § 102 cannot be performed.

However, the patent document cross-references several related applications within its own patent family, which establish its priority chain. These documents are considered prior art in terms of their filing dates for any subject matter in US12138052B1 that is not supported by an earlier priority document. For subject matter adequately disclosed and claimed in US12138052B1 that is fully supported by these earlier applications, they would serve as priority documents rather than anticipatory prior art.

The most relevant prior art cited within the "CROSS-REFERENCE TO RELATED APPLICATIONS" section of US12138052B1 are:

1. U.S. Provisional Application Ser. No. 62/196,797
   • Full Citation: U.S. Provisional Application Ser. No. 62/196,797
   • Publication/Filing Date: Filed on July 24, 2015
   • Brief Description: Titled "BLOOD CULTURE IMPROVEMENT SYSTEM AND METHOD." This provisional application is the earliest priority document for the patent family.
   • Potential Anticipation: As the foundational priority document, it primarily establishes the earliest effective filing date for the inventive concepts disclosed. If any claims in US12138052B1 are not fully supported by this provisional application, then this provisional application (or its subsequent non-provisional filings) could potentially anticipate those claims under 35 U.S.C. § 102 if the claims' effective filing date is later than the provisional's filing date. However, without the claims of US12138052B1, specific anticipation cannot be determined.

Other significant prior art within the patent family, serving as continuation applications, include:

1. U.S. Provisional Application Ser. No. 62/238,636

   • Full Citation: U.S. Provisional Application Ser. No. 62/238,636
   • Publication/Filing Date: Filed on October 7, 2015
   • Brief Description: Titled "BLOOD SEQUESTRATION SYSTEM FOR NON-CONTAMINATED BLOOD SAMPLING."
   • Potential Anticipation: Similar to the first provisional, this application further details aspects of the blood sequestration system. It would establish priority for subject matter disclosed therein.

2. U.S. Provisional Application Ser. No. 62/318,194

   • Full Citation: U.S. Provisional Application Ser. No. 62/318,194
   • Publication/Filing Date: Filed on April 4, 2016
   • Brief Description: Titled "BLOOD SAMPLE OPTIMIZATION SYSTEM AND BLOOD CONTAMINANT SEQUESTRATION DEVICE AND METHOD."
   • Potential Anticipation: This provisional application provides additional details for the blood sample optimization system and contaminant sequestration.

3. U.S. Pat. No. 10,010,282 (from U.S. application Ser. No. 15/140,448)

   • Full Citation: U.S. Pat. No. 10,010,282, issued July 3, 2018, from application Ser. No. 15/140,448 filed April 27, 2016.
   • Publication/Filing Date: Filed on April 27, 2016 (for the application)
   • Brief Description: Titled "BLOOD SAMPLE OPTIMIZATION SYSTEM AND BLOOD CONTAMINANT SEQUESTRATION DEVICE AND METHOD." This is a granted patent in the family.
   • Potential Anticipation: As a direct ancestor patent, its claims and disclosures would generally establish priority for later claims in US12138052B1 that are sufficiently supported by its disclosure. If US12138052B1 includes claims that are not adequately supported by the disclosure of 10,010,282 and have a later effective filing date, then the claims of 10,010,282 could potentially anticipate those new claims under 35 U.S.C. § 102.

4. U.S. Pat. No. 10,143,412 (from U.S. application Ser. No. 15/994,559)

   • Full Citation: U.S. Pat. No. 10,143,412, issued December 4, 2018, from application Ser. No. 15/994,559 filed May 31, 2018.
   • Publication/Filing Date: Filed on May 31, 2018 (for the application)
   • Brief Description: Titled "BLOOD SAMPLE OPTIMIZATION SYSTEM AND BLOOD CONTAMINANT SEQUESTRATION DEVICE AND METHOD."
   • Potential Anticipation: Similar to other family members, its disclosures and claims would generally establish priority.

5. U.S. Pat. No. 11,185,266 (from U.S. application Ser. No. 16/208,559)

   • Full Citation: U.S. Pat. No. 11,185,266, issued November 30, 2021, from application Ser. No. 16/208,559 filed December 4, 2018.
   • Publication/Filing Date: Filed on December 4, 2018 (for the application)
   • Brief Description: Titled "BLOOD SAMPLE OPTIMIZATION SYSTEM AND BLOOD CONTAMINANT SEQUESTRATION DEVICE AND METHOD."
   • Potential Anticipation: Continuation in the patent family, serving to preserve priority for common subject matter.

6. U.S. Pat. No. 11,963,769 (from U.S. application Ser. No. 17/538,990)

   • Full Citation: U.S. Pat. No. 11,963,769, from application Ser. No. 17/538,990 filed November 11, 2021.
   • Publication/Filing Date: Filed on November 11, 2021 (for the application)
   • Brief Description: Titled "BLOOD SAMPLE OPTIMIZATION DEVICE."
   • Potential Anticipation: Another continuation patent in the family.

7. U.S. Pat. No. 11,832,994 (from U.S. application Ser. No. 18/113,710)

   • Full Citation: U.S. Pat. No. 11,832,994, from application Ser. No. 18/113,710 filed February 24, 2023.
   • Publication/Filing Date: Filed on February 24, 2023 (for the application)
   • Brief Description: Titled "BLOOD SAMPLE OPTIMIZATION DEVICE."
   • Potential Anticipation: Another continuation patent in the family.

8. U.S. application Ser. No. 18/494,622

   • Full Citation: U.S. application Ser. No. 18/494,622
   • Publication/Filing Date: Filed on October 25, 2023
   • Brief Description: Titled "BLOOD SAMPLE OPTIMIZATION DEVICE."
   • Potential Anticipation: This is a continuation application leading up to the current patent.

In summary, these documents constitute the priority chain for US12138052B1. While they technically have earlier filing/publication dates, their primary role is to establish the effective filing date for the subject matter contained within US12138052B1. They would only anticipate claims in US12138052B1 if those claims represent "new matter" not supported by the earlier disclosures and thus have a later effective filing date, or if there's a specific reason for them not to benefit from the priority chain for certain claim elements. Without the actual claims of US12138052B1, it's impossible to identify specific anticipations.